Invention Grant
- Patent Title: Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof
-
Application No.: US16610055Application Date: 2018-04-27
-
Publication No.: US11066420B2Publication Date: 2021-07-20
- Inventor: Anthony B. Pinkerton , Robert J. Ardecky , Jiwen Zou
- Applicant: Sanford Burnham Prebys Medical Discovery Institute
- Applicant Address: US CA La Jolla
- Assignee: Sanford Burnham Prebys Medical Discovery Institute
- Current Assignee: Sanford Burnham Prebys Medical Discovery Institute
- Current Assignee Address: US CA La Jolla
- Agency: Wilson Sonsini Goodrich & Rosati
- International Application: PCT/US2018/029749 WO 20180427
- International Announcement: WO2018/204176 WO 20181108
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D401/12 ; C07D475/04 ; A61K31/5377 ; A61K31/4985 ; A61K31/498 ; C07D519/00 ; A61P3/04 ; A61K45/06

Abstract:
Protein tyrosine phosphatases (PTPs) are key regulators of metabolism and insulin signaling. As a negative regulator of insulin signaling, the low molecular weight protein tyrosine phosphatase (LMPTP) is a target for insulin resistance and related conditions. Described herein are compounds capable of modulating the level of activity of low molecular weight protein tyrosine phosphatase (LMPTP) and compositions, and methods of using these compounds and compositions.
Public/Granted literature
- US20200055875A1 INHIBITORS OF LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE (LMPTP) AND USES THEREOF Public/Granted day:2020-02-20
Information query